In this section
@article{Kemp:2025:10.1136/thorax-2024-221901,
author = {Kemp, PR and Griffiths, M and Polkey, MI and Sathyapala, A},
doi = {10.1136/thorax-2024-221901},
journal = {Thorax},
pages = {520--529},
title = {Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline},
url = {http://dx.doi.org/10.1136/thorax-2024-221901},
volume = {80},
year = {2025}
}
TY - JOUR
AB - Background: Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of life. The contribution of inflammation to muscle loss and the susceptibility to rapid lung function decline is debated. We hypothesised that comparing the muscle transcriptome to circulating inflammatory cytokine profiles in patients would identify any contribution of systemic inflammation to muscle atrophy.Methods: Quadriceps differential gene expression was determined between mild-COPD (n=28) and severe-COPD (n=51) using GSE100281. These microarray data were compared by biweight mid-correlation with lung function and plasma cytokine levels from the same patients.Results: Patients with severe COPD had reduced fat-free mass index (a measurement of muscle mass) compared with patients with mild COPD despite similar physical activity and inflammatory cytokine levels. Gene sets associated with inflammation and epithelial mesenchymal transition (EMT) were elevated in severe COPD, suggesting that inflammation may contribute to the loss of muscle mass. In patients with severe COPD, EMT and inflammation gene sets were strongly associated with circulating proinflammatory and anti-inflammatory cytokines. However, in patients with mild COPD, anti-inflammatory cytokines showed negative associations with these gene sets and associations with proinflammatory cytokines were weak. In data from lung and blood samples, patients with severe COPD had elevated inflammatory and EMT gene expression compared with patients with mild COPD suggesting that this phenomenon is not muscle-specific.Conclusions: In patients at the severe end of the COPD spectrum, the proinflammatory response in muscle predominates, whereas in patients at the mild end of the spectrum, the anti-inflammatory response predominates. This suggestion needs confirming in a longitudinal cohort.
AU - Kemp,PR
AU - Griffiths,M
AU - Polkey,MI
AU - Sathyapala,A
DO - 10.1136/thorax-2024-221901
EP - 529
PY - 2025///
SN - 0040-6376
SP - 520
TI - Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline
T2 - Thorax
UR - http://dx.doi.org/10.1136/thorax-2024-221901
UR - https://doi.org/10.1136/thorax-2024-221901
VL - 80
ER -